Investigators have discovered why Huntington’s disease is so toxic to cancer cells and are harnessing it as a novel approach to treat cancer.
Browsing: Taxonomy > Pathology and cancer biology
A PGE2-receptor type-4 inhibitor, termed E7046, has demonstrated promising clinical activity in a Phase I trial of patients with advanced solid tumors.
A novel viral-gene therapy could improve results from breast reconstruction surgery after cancer treatment by helping healthy tissue protect itself from radiotherapy damage.
An innovative new platform could transform the way cancer is diagnosed and treated by automating the isolation of circulating tumor cells.
In this review piece, we take a look at the most read cancer news stories from over the past year; highlights include drug approvals, genetic discoveries and immunotherapy advancements.
Find out about the characteristics of patient-derived xenograft models and their application for basic & preclinical cancer research in this editorial from Future Science OA.
Scientists have revealed that a human protein – identified as YTHDF2 – could prevent cancer by restricting the human herpes virus 8, otherwise known as Kaposi’s sarcoma-associated herpesvirus.
A team of scientists have bound gene editing CRISPR/Cas9 to nucleotide aptamers to selectively target and edit osteosarcoma cancer cells.
Researchers have demonstrated that breast cancer can resurface 15 years after treatment, epigenetic editing has revealed a surprising insight into early breast cancer development and two breakthrough CDK4/6-inhibitor drugs have been approved for advanced breast cancer.
Researchers at the Ludwig Institute for Cancer Research (Brussels, Belgium) have discovered a novel mechanism used by tumors to evade immunotherapies.